{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:22:38Z","timestamp":1787289758796,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpsychires.2025.05.062","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T19:08:24Z","timestamp":1748286504000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9313-4459","authenticated-orcid":false,"given":"Kristoffer A.A.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2166-1760","authenticated-orcid":false,"given":"Bj\u00f8rn","family":"Holm\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-1511","authenticated-orcid":false,"given":"Tor-Morten","family":"Kvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7068-0513","authenticated-orcid":false,"given":"Matthew W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.062_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.13249","article-title":"Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern-era clinical studies","volume":"143","author":"Andersen","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib3","series-title":"Navigating Groundlessness: an Interview Study on Dealing with Ontological Shock and Existential Distress Following Psychedelic Experiences","author":"Argyri","year":"2024"},{"issue":"12","key":"10.1016\/j.jpsychires.2025.05.062_bib4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajp.22010073","article-title":"A case of prolonged mania, psychosis, and severe depression after psilocybin use: implications of increased psychedelic drug availability","volume":"179","author":"Barber","year":"2022","journal-title":"Am. J. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2025.05.062_bib5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0269881116678781","article-title":"The Challenging Experience Questionnaire: characterization of challenging experiences with psilocybin mushrooms","volume":"30","author":"Barrett","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.05.062_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.jpsychires.2025.05.062_bib7","article-title":"Adverse effects of ayahuasca: results from the global ayahuasca survey","volume":"2","author":"Bouso","year":"2022","journal-title":"PLOS Global Pub Health"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41145-x","article-title":"Case analysis of long-term negative psychological responses to psychedelics","volume":"13","author":"Bremler","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib9","series-title":"Confirmatory Factor Analysis for Applied Research","author":"Brown","year":"2015"},{"issue":"12","key":"10.1016\/j.jpsychires.2025.05.062_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.05.062_bib11","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"17","key":"10.1016\/j.jpsychires.2025.05.062_bib12","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.062_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/10705510701301834","article-title":"Sensitivity of goodness of fit indexes to lack of measurement invariance","volume":"14","author":"Chen","year":"2007","journal-title":"Struct. Equ. Model.: A Multidiscip. J."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.062_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.05.062_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.05.062_bib16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.062_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264927","article-title":"Phenomenological assessment of psychedelics induced experiences: translation and validation of the German challenging experience questionnaire (CEQ) and ego-dissolution inventory (EDI)","volume":"17","author":"Dworatzyk","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00038-012-0416-3","article-title":"The reliability of a two-item scale: pearson, Cronbach, or Spearman-Brown?","volume":"58","author":"Eisinga","year":"2013","journal-title":"Int. J. Publ. Health"},{"issue":"10","key":"10.1016\/j.jpsychires.2025.05.062_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293349","article-title":"Extended difficulties following the use of psychedelic drugs: a mixed methods study","volume":"18","author":"Evans","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102997","article-title":"Making \u201cbad trips\u201d good: how users of psychedelics narratively transform challenging trips into valuable experiences","volume":"87","author":"Gashi","year":"2021","journal-title":"Int. J. Drug Pol."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.05.062_bib21","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41386-023-01648-7","article-title":"Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication","volume":"48","author":"Goodwin","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.05.062_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.062_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.062_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.062_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives","volume":"6","author":"Hu","year":"1999","journal-title":"Struct. Equ. Model.: A Multidiscip. J."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1556\/2054.2021.00167","article-title":"Have Norwegians tried psilocybin, and do they accept it as a medicine?","volume":"5","author":"Jacobsen","year":"2021","journal-title":"J. Psychedelic Studies"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.062_bib29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1556\/2054.2021.00155","article-title":"Day trip to hell: a mixed methods study of challenging psychedelic experiences","volume":"5","author":"Johnstad","year":"2021","journal-title":"J. Psychedelic Studies"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.062_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1556\/2054.2022.00199","article-title":"Being no one, being One: the role of ego-dissolution and connectedness in the therapeutic effects of psychedelic experience","volume":"6","author":"Ka\u0142u\u017cna","year":"2022","journal-title":"J. Psychedelic Studies"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41398-024-03116-2","article-title":"Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects","volume":"14","author":"Klaiber","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.917199","article-title":"Psychedelics, mystical experience, and therapeutic efficacy: a systematic review","volume":"13","author":"Ko","year":"2022","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib33","article-title":"A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history","volume":"2","author":"Kramer","year":"2023","journal-title":"Psych. Res. Case Rep."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1287196","article-title":"Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample","volume":"14","author":"Kvam","year":"2023","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib35","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.062_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/02698811241232548","article-title":"Psychiatric risks for worsened mental health after psychedelic use","volume":"38","author":"Marrocu","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib37","series-title":"Monitoring the Future National Survey Results on Drug Use, 1975-2022: Secondary School Students","author":"Miech","year":"2023"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/02698811221131997","article-title":"Risks and benefits of psilocybin use in people with bipolar disorder: an international web-based survey on experiences of \u2018magic mushroom\u2019consumption","volume":"37","author":"Morton","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jpsychires.2025.05.062_bib39","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","article-title":"Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study","volume":"29","author":"Peck","year":"2023","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.jpsychires.2025.05.062_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib41","series-title":"Psych: Procedures for Personality and Psychological Research","author":"Revelle","year":"2017"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1369715","article-title":"Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs","volume":"15","author":"Robinson","year":"2024","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib43","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: an R package for structural equation modeling","volume":"48","author":"Rosseel","year":"2012","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2023.01.073","article-title":"Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics","volume":"326","author":"Simonsson","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/02698811231199112","article-title":"The revival of the psychedelic experience scale: revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies","volume":"38","author":"Stocker","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/2054.2018.003","article-title":"The psychedelic religion of mystical consciousness","volume":"2","author":"Strassman","year":"2018","journal-title":"J. Psychedelic Studies"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.062_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/psymed.2023.0046","article-title":"The mystical experience questionnaire 4-item and challenging experience questionnaire 7-item","volume":"2","author":"Strickland","year":"2024","journal-title":"Psychedelic Med."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib49","article-title":"Trends in hallucinogen-associated emergency department visits and hospitalizations in California from 2016-2021","author":"Tate","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib50","article-title":"RA language and environment for statistical computing, R Foundation for Statistical","author":"Team","year":"2020","journal-title":"Computing (U. K.)"},{"issue":"7","key":"10.1016\/j.jpsychires.2025.05.062_bib51","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.euroneuro.2016.03.012","article-title":"Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans","volume":"26","author":"Valle","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231198466","article-title":"History repeating: guidelines to address common problems in psychedelic science","volume":"13","author":"van Elk","year":"2023","journal-title":"Therapeutic Adv. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.675768","article-title":"On perception and consciousness in HPPD: a systematic review","volume":"15","author":"Vis","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.05.062_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41398-024-03074-9","article-title":"Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants","volume":"14","author":"Vizeli","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"17","key":"10.1016\/j.jpsychires.2025.05.062_bib55","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib56","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.062_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation","volume":"8","author":"Wild","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.jpsychires.2025.05.062_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front. Psychiatr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625003620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625003620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:12:24Z","timestamp":1778944344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625003620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"alternative-id":["S0022395625003620"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.05.062","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.05.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}